HCPCS drug code · CMS crosswalk
Vancomycin HCl J-Code / HCPCS Code
In short
CMS assigns Vancomycin HCl NDCs to 4 HCPCS codes: J3373 (per 10 mg), J3374 (per 10 mg), J3375 (per 10 mg), J3376 (per 10 mg). Which one applies depends on the product; the table lists each NDC with its code.
J3373 code detailsJ3374 code detailsJ3375 code detailsJ3376 code details
Reference
- J3373
- Injection, vancomycin hydrochloride, 10 mgBilling unit: 10 mg
- J3374
- Injection, vancomycin hydrochloride (mylan) not therapeutically equivalent to j3373, 10 mgBilling unit: 10 mg
- J3375
- Injection, vancomycin hydrochloride (tyzavan), not therapeutically equivalent to j3373, 10 mgBilling unit: 10 mg
- J3376
- Injection, vancomycin hcl (hikma), not therapeutically equivalent to j3373, 10 mgBilling unit: 10 mg
- Labelers
- Athenex Pharmaceutical Division, LLC; Baxter Healthcare Corporation; BluePoint Laboratories; Civica, Inc.; Eugia US LLC; FreseniUS Kabi USA, LLC; Glenmark Pharmaceuticals Inc., USA; Henry Schein Inc.and 9 more
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Medicare Part B payment limit
CMS ASP fileEffective October 1, 2026 through December 31, 2026. Payment allowance limits subject to the ASP methodology are based on 2Q26 ASP data. A payment limit is not a coverage decision; the Medicare contractor decides coverage. CMS ASP pricing files
Vancomycin HCl units and claim line
Enter the dose given to get the J3373 units and the NDC line for the CMS-1500 and the 837P. This builds the J3373 line; use the code page for J3374, J3375, J3376.
Enter the dose given to build the claim line.
Vancomycin HCl NDCs and billing units
From CMS’s ASP NDC–HCPCS crosswalk, effective October 1, 2026 through December 31, 2026. Billing units per package are CMS’s figures for the code’s unit.
| NDC (11-digit) | HCPCS | Labeler | Package | Billing units per package |
|---|---|---|---|---|
| 00143-9355-10 | J3373 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 750 |
| 00143-9357-10 | J3373 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 1000 |
| 00143-9358-01 | J3373 | Hikma Pharmaceuticals USA Inc. | 1 | 500 |
| 00143-9359-01 | J3373 | Hikma Pharmaceuticals USA Inc. | 1 | 1000 |
| 00338-0122-04 | J3373 | Baxter Healthcare Corporation | 4 × 250 | 500 |
| 00338-0124-04 | J3373 | Baxter Healthcare Corporation | 4 × 300 | 600 |
| 00338-3551-48 | J3373 | Baxter Healthcare Corporation | 100 | 600 |
| 00338-3552-48 | J3373 | Baxter Healthcare Corporation | 200 | 600 |
| 00338-3580-48 | J3373 | Baxter Healthcare Corporation | 150 | 450 |
| 00338-3581-01 | J3373 | Baxter Healthcare Corporation | 100 | 600 |
| 00338-3582-01 | J3373 | Baxter Healthcare Corporation | 150 | 450 |
| 00338-3583-01 | J3373 | Baxter Healthcare Corporation | 200 | 600 |
| 00404-9965-99 | J3373 | Henry Schein Inc. | 1 | 50 |
| 00409-1319-01 | J3373 | Pfizer Inc | 1 | 1000 |
| 00409-3515-01 | J3373 | Pfizer Inc | 10 × 1 | 1500 |
| 00409-4332-01 | J3373 | Pfizer Inc | 10 × 1 | 500 |
| 00409-5017-01 | J3373 | Pfizer Inc | 1 | 1000 |
| 00409-6509-01 | J3373 | Pfizer Inc | 1 | 500 |
| 00409-6509-49 | J3373 | Pfizer Inc | 1 | 500 |
| 00409-6531-01 | J3373 | Pfizer Inc | 10 × 1 | 750 |
| 00409-6531-02 | J3373 | Pfizer Inc | 10 × 1 | 750 |
| 00409-6533-21 | J3373 | Pfizer Inc | 10 × 1 | 1000 |
| 00409-6533-31 | J3373 | Pfizer Inc | 10 × 1 | 1000 |
| 00409-6534-01 | J3373 | Pfizer Inc | 10 × 1 | 500 |
| 00409-6535-01 | J3373 | Pfizer Inc | 10 × 1 | 1000 |
| 16714-0309-10 | J3373 | Northstar RxLLC | 10 × 1 | 1000 |
| 25021-0150-10 | J3373 | Sagent Pharmaceuticals | 10 × 1 | 500 |
| 25021-0151-20 | J3373 | Sagent Pharmaceuticals | 10 × 1 | 1000 |
| 25021-0157-99 | J3373 | Sagent Pharmaceuticals | 1 | 500 |
| 25021-0158-99 | J3373 | Sagent Pharmaceuticals | 1 | 1000 |
| 63323-0203-20 | J3373 | FreseniUS Kabi USA, LLC | 10 × 1 | 750 |
| 63323-0203-26 | J3373 | FreseniUS Kabi USA, LLC | 10 × 1 | 750 |
| 63323-0221-10 | J3373 | FreseniUS Kabi USA, LLC | 25 × 1 | 1250 |
| 63323-0221-16 | J3373 | FreseniUS Kabi USA, LLC | 25 × 1 | 1250 |
| 63323-0284-20 | J3373 | FreseniUS Kabi USA, LLC | 10 × 1 | 1000 |
| 63323-0284-26 | J3373 | FreseniUS Kabi USA, LLC | 10 × 1 | 1000 |
| 63323-0295-61 | J3373 | FreseniUS Kabi USA, LLC | 1 | 500 |
| 63323-0295-66 | J3373 | FreseniUS Kabi USA, LLC | 1 | 500 |
| 63323-0314-61 | J3373 | FreseniUS Kabi USA, LLC | 1 | 1000 |
| 63323-0314-66 | J3373 | FreseniUS Kabi USA, LLC | 1 | 1000 |
| 67457-0339-50 | J3373 | Mylan Institutional LLC | 10 × 1 | 500 |
| 67457-0340-01 | J3373 | Mylan Institutional LLC | 10 × 1 | 1000 |
| 67457-0341-05 | J3373 | Mylan Institutional LLC | 1 | 500 |
| 67457-0342-10 | J3373 | Mylan Institutional LLC | 1 | 1000 |
| 68001-0407-75 | J3373 | BluePoint Laboratories | 1 | 1000 |
| 68462-0955-51 | J3373 | Glenmark Pharmaceuticals Inc., USA | 10 × 1 | 500 |
| 68462-0956-11 | J3373 | Glenmark Pharmaceuticals Inc., USA | 10 × 1 | 1000 |
| 70436-0020-82 | J3373 | Slate Run Pharmaceuticals | 10 × 1 | 500 |
| 70436-0021-82 | J3373 | Slate Run Pharmaceuticals | 10 × 1 | 1000 |
| 70436-0022-82 | J3373 | Slate Run Pharmaceuticals | 1 | 500 |
| 70436-0023-82 | J3373 | Slate Run Pharmaceuticals | 1 | 1000 |
| 70594-0045-02 | J3373 | Xellia Pharmaceuticals USA, LLC. | 10 × 1 | 500 |
| 70594-0046-02 | J3373 | Xellia Pharmaceuticals USA, LLC. | 10 × 1 | 1000 |
| 70594-0047-01 | J3373 | Xellia Pharmaceuticals USA, LLC. | 1 | 500 |
| 70594-0048-01 | J3373 | Xellia Pharmaceuticals USA, LLC. | 1 | 1000 |
| 70594-0122-02 | J3373 | Xellia Pharmaceuticals USA, LLC. | 10 × 1 | 500 |
| 70594-0123-02 | J3373 | Xellia Pharmaceuticals USA, LLC. | 10 × 1 | 1000 |
| 70860-0104-10 | J3373 | Athenex Pharmaceutical Division, LLC | 10 × 1 | 500 |
| 70860-0105-20 | J3373 | Athenex Pharmaceutical Division, LLC | 10 × 1 | 1000 |
| 71288-0022-11 | J3373 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 500 |
| 71288-0023-21 | J3373 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 1000 |
| 71288-0024-21 | J3373 | Meitheal Pharmaceuticals Inc. | 10 × 1 | 750 |
| 71288-0025-75 | J3373 | Meitheal Pharmaceuticals Inc. | 1 | 500 |
| 71288-0026-75 | J3373 | Meitheal Pharmaceuticals Inc. | 1 | 1000 |
| 72572-0029-10 | J3373 | Civica, Inc. | 10 × 1 | 1000 |
| 72572-0105-01 | J3373 | Civica, Inc. | 1 | 500 |
| 72572-0207-01 | J3373 | Civica, Inc. | 1 | 1000 |
| 72572-0801-02 | J3373 | Civica, Inc. | 10 × 1 | 1000 |
| 72572-0803-01 | J3373 | Civica, Inc. | 1 | 500 |
| 72572-0805-01 | J3373 | Civica, Inc. | 1 | 1000 |
| 00143-9152-10 | J3374 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 1250 |
| 00143-9153-10 | J3374 | Hikma Pharmaceuticals USA Inc. | 10 × 1 | 1500 |
| 25021-0147-20 | J3374 | Sagent Pharmaceuticals | 10 × 1 | 750 |
| 25021-0148-30 | J3374 | Sagent Pharmaceuticals | 10 × 1 | 1250 |
| 25021-0149-30 | J3374 | Sagent Pharmaceuticals | 10 × 1 | 1500 |
| 39822-0460-02 | J3374 | XGen Pharmaceuticals DJB, Inc. | 10 × 1 | 1250 |
| 39822-0470-02 | J3374 | XGen Pharmaceuticals DJB, Inc. | 10 × 1 | 1500 |
| 55150-0471-10 | J3374 | Eugia US LLC | 10 × 1 | 1250 |
| 55150-0472-10 | J3374 | Eugia US LLC | 10 × 1 | 1500 |
| 67457-0705-75 | J3374 | Mylan Institutional LLC | 10 × 1 | 750 |
Vancomycin HCl: common questions
- What is the J-code for Vancomycin HCl?
- CMS assigns Vancomycin HCl NDCs to 4 HCPCS codes: J3373 (per 10 mg), J3374 (per 10 mg), J3375 (per 10 mg), J3376 (per 10 mg). Which one applies depends on the product; the table lists each NDC with its code.
- How many J3373 billing units are in a package of Vancomycin HCl?
- CMS lists 50 to 1,500 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- How many J3374 billing units are in a package of Vancomycin HCl?
- CMS lists 750 to 2,000 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- How many J3375 billing units are in a package of Vancomycin HCl?
- CMS lists 600 to 1,200 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- How many J3376 billing units are in a package of Vancomycin HCl?
- CMS lists 500 to 1,250 billing units per package, depending on the NDC, where one unit is 10 mg. Units to report are based on the dose given, not the package.
- Is J3373 a CPT code?
- No. J3373 is a HCPCS Level II code from CMS for the drug itself. Giving it, for example by injection or infusion, is usually reported with a separate CPT administration code.